Drug Type Small molecule drug |
Synonyms Naproxen sodium/lansoprazole, PN 100, PN-100 + [3] |
Target |
Action inhibitors |
Mechanism ATPase inhibitors(ATPase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseWithdrawn |
First Approval Date United States (14 Nov 2003), |
Regulation- |
Molecular FormulaC14H14O3 |
InChIKeyCMWTZPSULFXXJA-VIFPVBQESA-N |
CAS Registry22204-53-1 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Stomach Ulcer | United States | 14 Nov 2003 |





